Tag: Liquid Biopsy
-
New Blood Test Enables Real-Time Detection and Monitoring of Lung Cancer
Groundbreaking Step in Lung Cancer Care A new blood test developed by researchers in the United Kingdom could change how lung cancer is diagnosed and tracked. The test, described by scientists as a pioneering approach, aims to detect lung cancer and monitor its progression in real time using a simple blood sample. If validated in…
-
New blood test can detect and monitor lung cancer in real time
Revolutionizing lung cancer care with a real-time blood test A promising breakthrough from UK researchers promises to transform how clinicians detect and monitor lung cancer. The new blood test, described as a form of liquid biopsy, aims to provide real-time insights into tumor activity. By analyzing circulating tumor signals in a patient’s blood, doctors could…
-
Princess Margaret Cancer Centre Launches Global-First $50-Million Early Detection Research Initiative
Ontario’s Princess Margaret Cancer Centre Announces a Pioneering $50-Million Initiative The Princess Margaret Cancer Centre in Toronto has unveiled a bold new commitment to transforming cancer outcomes through early detection. In a move described by organizers as the largest program of its kind globally, the center is launching a $50-million research initiative aimed at identifying…
-
Oncomarkers Awareness Day: Advancing Precision Oncology Through Biomarker Science
Introduction: A Global Day for Biomarker Science Oncomarkers Awareness Day, first observed on November 13, 2025, marks a milestone in the cancer care landscape. This international observance highlights how biomarkers—the measurable indicators of biological processes—are shaping precision oncology. By providing richer diagnostic insights, guiding therapy choices, and monitoring treatment response, biomarkers are helping clinicians tailor…
-
Pancreatic Cancer Research Project Targets Seeds of Metastasis
New Frontiers in Pancreatic Cancer Research Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest forms of cancer, with a five-year survival rate that has stubbornly lingered in the single digits. A recent research initiative is focusing on a critical phase of disease progression: the early steps that allow pancreatic cancer cells to seed distant…
-
Exact Sciences Unveils Breakthrough Blood Test for Early Liver Cancer Detection
Groundbreaking Validation of a Blood-Based Liver Cancer Screening Tool Exact Sciences Corp. has announced pivotal clinical validation results from the ALTUS study, a prospective, head-to-head evaluation designed to assess a blood-based surveillance test for liver cancer. Conducted in a real-world, high-risk population, the ALTUS study (NCT: 05064553) represents a major step toward accessible, non-invasive screening…
-
Living with cancer in Ireland: how personalized treatment is changing outcomes
Growing a new approach: from one-size-fits-all to personalized cancer care In Ireland, the cancer landscape has shifted dramatically in the last decade. The story of Lydia Whelan, a 32-year-old diagnosed with stage 2 HER2+ breast cancer in 2024, reflects a broader national trend: treatments are becoming more tailored, more precise, and more hopeful for patients…
-
Living with cancer in Ireland: We’ve moved from a one-size-fits-all treatment
From uniform treatments to personalised cancer care In Ireland, the cancer treatment landscape has shifted dramatically over the last decade. Patients who once faced a one-size-fits-all approach now benefit from personalised strategies that target the biology of their disease. For Lydia Whelan, a 32-year-old diagnosed with stage 2 HER2+ breast cancer in 2024, this evolution…
-
Head and Neck Cancer Breakthrough: A Blood Test Detects Cancer Up to 10 Years Early
Overview: A Potential Turning Point in Cancer Screening Researchers have unveiled a groundbreaking approach that could transform how we screen for head and neck cancers, particularly those linked to the human papillomavirus (HPV). Using a simple blood sample, the new test aims to detect the presence of tumor-derived DNA circulating in the blood (circulating tumor…
-
Head and Neck Cancer: How a Simple Blood Test Can Detect Cancer Up to 10 Years Early
Introduction: A new frontier in cancer screening Imagine having a precautionary tool for cancer, much like a flu vaccine you take before the season. A team of researchers may have brought us a breakthrough that moves us closer to that reality for head and neck cancers. Using a simple blood test, they demonstrated the potential…